- Home
- HOG vs OLMA Comparison
HOG vs OLMA Comparison
Compare HOG & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOG | OLMA |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HOG | OLMA |
|---|---|---|
| Price | $20.60 | $26.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $27.43 | ★ $41.14 |
| AVG Volume (30 Days) | ★ 2.6M | 1.3M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | ★ $4,664,627,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.04 | N/A |
| P/E Ratio | $5.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.90 | $2.86 |
| 52 Week High | $31.25 | $36.26 |
Technical Indicators
Market Signals| Indicator | HOG | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 49.53 |
| Support Level | $19.90 | $25.83 |
| Resistance Level | $21.46 | $29.50 |
| Average True Range (ATR) | 0.55 | 1.59 |
| MACD | 0.09 | -0.30 |
| Stochastic Oscillator | 57.74 | 47.43 |
Price Performance
Historical ComparisonAbout HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.